Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review
Physicians integrate GLP-1 treatments with nutritional counseling, lifestyle modifications, and behavioral supportall essential for long-term success
People think of it as a miracle drug, she says, but there are so many unknowns.
The FDA-approved labels for these agents list nausea, vomiting, and decreased appetite as common adverse effects, though taste alterations are not prominently featured in US prescribing information for most of these medications
Combining them may intensify these gastrointestinal effects, leading to greater discomfort without proportionally enhanced weight loss
